|
Volumn 33, Issue 7-8, 2001, Pages 3862-3864
|
Ancient proteins and futuristic surgery: The role of complement in discordant xenograft rejection
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CLASSICAL COMPLEMENT PATHWAY C3 C5 CONVERTASE;
COMPLEMENT COMPONENT C1S INHIBITOR;
CREATININE;
CYCLOPHOSPHAMIDE;
DECAY ACCELERATING FACTOR;
STEROID;
UREA;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTIBODY BLOOD LEVEL;
ANTIGEN BINDING;
ARTICLE;
B LYMPHOCYTE;
CELL ACTIVATION;
COMPLEMENT ACTIVATION;
CONTROLLED STUDY;
CREATININE BLOOD LEVEL;
ENDOTHELIUM CELL;
GRAFT REJECTION;
HUMORAL IMMUNITY;
IMMUNOSUPPRESSIVE TREATMENT;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
NONHUMAN;
ORGAN DONOR;
PATHOPHYSIOLOGY;
PRIMATE;
PRIORITY JOURNAL;
RECIPIENT;
REPERFUSION;
SURVIVAL TIME;
SWINE;
TRANSGENIC ANIMAL;
UREA BLOOD LEVEL;
XENOTRANSPLANTATION;
ANIMALS;
ANIMALS, GENETICALLY MODIFIED;
ANTIGENS, CD55;
COMPLEMENT SYSTEM PROTEINS;
GRAFT REJECTION;
TRANSPLANTATION IMMUNOLOGY;
TRANSPLANTATION, HETEROLOGOUS;
|
EID: 0035672614
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02637-9 Document Type: Article |
Times cited : (2)
|
References (21)
|